Lv2
140 积分 2024-02-02 加入
The clinical landscape of HIF2α inhibitors in oncology
11小时前
待确认
Casdatifan (AB521) is a novel and potent allosteric small molecule inhibitor of protumourigenic HIF-2α dependent transcription
9天前
已完结
The clinical landscape of HIF2α inhibitors in oncology
12天前
已完结
Belzutifan's role in the treatment landscape of clear cell renal cell carcinoma
14天前
已关闭
First and Second-line Treatments in Metastatic Renal Cell Carcinoma
14天前
已完结
AML treatment: conventional chemotherapy and emerging novel agents
27天前
已完结
Advances in renal cancer: diagnosis, treatment, and emerging technologies
1个月前
已完结
Von Hippel–Lindau protein signalling in clear cell renal cell carcinoma
1个月前
已完结
Epidemiology of Renal Cancer: Incidence, Mortality, Survival, Genetic Predisposition, and Risk Factors
1个月前
已完结
Therapeutic targeting of the hypoxic tumour microenvironment
1个月前
已完结
皖公网安备34019202002308
